Intervention Review

Haloperidol versus chlorpromazine for schizophrenia

  1. Claudia Leucht1,*,
  2. Maria Kitzmantel2,
  3. John Kane3,
  4. Stefan Leucht1,
  5. Wan Lian LC Chua4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 12 NOV 2007

DOI: 10.1002/14651858.CD004278.pub2


How to Cite

Leucht C, Kitzmantel M, Kane J, Leucht S, Chua WLLC. Haloperidol versus chlorpromazine for schizophrenia. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD004278. DOI: 10.1002/14651858.CD004278.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    München, Germany

  3. 3

    The Zucker Hillside Hospital, Psychiatry, New York, USA

  4. 4

    Lynfield Hospital, Craven and Airedale Drugs and Alcohol Team, Bradford, West Yorkshire, UK

*Claudia Leucht, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Ismaningerstrasse 22, München, 81675, Germany. Claudia.Leucht@lrz.tu-muenchen.de. claudialeucht@gmx.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

  1. Current Version

    Haloperidol versus chlorpromazine for schizophrenia

    Claudia Leucht, Maria Kitzmantel, John Kane, Stefan Leucht and Wan Lian LC Chua

    Version of Record online: 23 JAN 2008 | DOI: 10.1002/14651858.CD004278.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Haloperidol versus chlorpromazine for schizophrenia

    C Mentschel, WL Chua, J Kane and S Leucht

    Version of Record online: 21 JUL 2003 | DOI: 10.1002/14651858.CD004278